04 September 2018 | News
This further strengthens the foothold Pharma To Market has in the APAC region with their existing offices in Australia and Singapore
Pharma To Market, a leading regulatory affairs consulting company operating in the Asia-Pacific region, further expanded their APAC footprint with the establishment of their Malaysian entity - Pharma To Market Sdn Bhd.
"This is exciting news as it enables our clients to gain a head-start for product registration within Malaysia without first needing to establish their own entity. Pharma To Market offers this service via a 'non-commercial license holding' agreement, which gives clients the flexibility to start the registration process prior to 'setting up' locally or finding a marketing partner. This complements our existing regulatory strategy and registration services that we already offer in Malaysia," said Joelle Chia, co-director, Pharma To Market.
This news further strengthens the foothold Pharma To Market has in the APAC region with their existing offices in Australia and Singapore. "We are excited to offer this service to our existing and new clients as it enables our clients to expand their product portfolio across the region," said Johanna Hann, co-director, Pharma To Market.
Pharma To Market has undergone a strong period of growth over the last 18 months with the Singapore office established only last year. "We are proud of Pharma To Market's organic growth, made possible by the strong foundations of Pharma To Market's business practices, reputation and brand," said Nick Ward, co-director, Pharma To Market.